Confluence switch signaling regulates ECM composition and the plasmin proteolytic cascade in keratinocytes

Journal of Cell Science

Volumn 125, Issue 18, 2012, Pages 4241-4252

  Botta, Adrien ^a,b   Delteil, Frédé ric ^a,b   Mettouchi, Amel ^a,b   Vieira, Andhira ^a,b   Estrach, Soline ^a,b   Négroni, Luc ^b,d   Stefani, Caroline ^c   Lemichez, E ^c   Meneguzzi, Guerrino ^a,b   Gagnoux Palacios, Laurent ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^d CNRS   (France)

Author keywords

Basement membrane; Extracellular matrix; Keratinocyte; Protease

Indexed keywords

ACTIVIN A; ANTITHROMBIN III; COLLAGEN TYPE 1; CYCLIN A; CYTOKERATIN 10; LAMININ; MASPIN; MESSENGER RNA; PERLECAN; PLASMIN; TENASCIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA; VITRONECTIN;

ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL JUNCTION; CELL MATURATION; CELL MIGRATION; CELL MOTILITY; CELL MOTION; CELL PROLIFERATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE SWITCHING; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; UPREGULATION; WOUND HEALING;

ACTIVINS; ADHERENS JUNCTIONS; ANIMALS; BASEMENT MEMBRANE; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; EXTRACELLULAR MATRIX; FEEDBACK, PHYSIOLOGICAL; FIBRINOLYSIN; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; KERATINOCYTES; MICE; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BINDING; PROTEOLYSIS; PROTEOMICS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; WOUND HEALING;

EID: 84872191935     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.096289     Document Type: Article

References (57)

1. Aberdam, D., Galliano, M. F., Vailly, J., Pulkkinen, L., Bonifas, J., Christiano, A. M., Tryggvason, K., Uitto, J., Epstein, E. H., Jr, Ortonne, J. P. et al. (1994). Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Nat. Genet. 6, 299-304.
2. Arroyo De Prada, N., Schroeck, F., Sinner, E. K., Muehlenweg, B., Twellmeyer, J., Sperl, S., Wilhelm, O. G., Schmitt, M. and Magdolen, V. (2002). Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin. Eur. J. Biochem. 269, 184-192.
3. Bajou, K., Maillard, C., Jost, M., Lijnen, R. H., Gils, A., Declerck, P., Carmeliet, P., Foidart, J. M. and Noel, A. (2004). Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth. Oncogene 23, 6986-6990.
4. Baudoin, C., Fantin, L. and Meneguzzi, G. (2005). Proteolytic processing of the laminin alpha3 G domain mediates assembly of hemidesmosomes but has no role on keratinocyte migration. J. Invest. Dermatol. 125, 883-888.
5. Carter, W. G., Ryan, M. C. and Gahr, P. J. (1991). Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes. Cell 65, 599-610.
6. Chapman, H. A. (1997). Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 9, 714-724.
7. Chiellini, C., Cochet, O., Negroni, L., Samson, M., Poggi, M., Ailhaud, G., Alessi, M. C., Dani, C. and Amri, E. Z. (2008). Characterization of human mesenchymal stem cell secretome at early steps of adipocyte and osteoblast differentiation. BMC Mol. Biol. 9, 26.
8. Costell, M., Gustafsson, E., Aszó́di, A., Mörgelin, M., Bloch, W., Hunziker, E., Addicks, K., Timpl, R. and Fässler, R. (1999). Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol. 147, 1109-1122.
9. Czekay, R. P. and Loskutoff, D. J. (2004). Unexpected role of plasminogen activator inhibitor 1 in cell adhesion and detachment. Exp. Biol. Med. (Maywood) 229, 1090-1096.
10. Czekay, R. P., Wilkins-Port, C. E., Higgins, S. P., Freytag, J., Overstreet, J. M., Klein, R. M., Higgins, C. E., Samarakoon, R. and Higgins, P. J. (2011). PAI-1: An Integrator of Cell Signaling and Migration. Int. J. Cell Biol. 2011, 562481.
11. Declerck, P. J., De Mol, M., Alessi, M. C., Baudner, S., Pâques, E. P., Preissner, K. T., Müller-Berghaus, G. and Collen, D. (1988). Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J. Biol. Chem. 263, 15454-15461.
12. Degryse, B., Sier, C. F., Resnati, M., Conese, M. and Blasi, F. (2001). PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor. FEBS Lett. 505, 249-254.
13. Degryse, B., Neels, J. G., Czekay, R. P., Aertgeerts, K., Kamikubo, Y. and Loskutoff, D. J. (2004). The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1. J. Biol. Chem. 279, 22595-22604.
14. Devy, L., Blacher, S., Grignet-Debrus, C., Bajou, K., Masson, V., Gerard, R. D., Gils, A., Carmeliet, G., Carmeliet, P., Declerck, P. J. et al. (2002). The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J. 16, 147-154.
15. Eren, M., Gleaves, L. A., Atkinson, J. B., King, L. E., Declerck, P. J. and Vaughan, D. E. (2007). Reactive site-dependent phenotypic alterations in plasminogen activator inhibitor-1 transgenic mice. J. Thromb. Haemost. 5, 1500-1508.
16. Fuchs, E. (2007). Scratching the surface of skin development. Nature 445, 834-842.
17. Gagnoux-Palacios, L., Vailly, J., Durand-Clement, M., Wagner, E., Ortonne, J. P. and Meneguzzi, G. (1996). Functional Re-expression of laminin-5 in laminingamma2-deficient human keratinocytes modifies cell morphology, motility, and adhesion. J. Biol. Chem. 271, 18437-18444.
18. Gagnoux-Palacios, L., Allegra, M., Spirito, F., Pommeret, O., Romero, C., Ortonne, J. P. and Meneguzzi, G. (2001). The short arm of the laminin gamma2 chain plays a pivotal role in the incorporation of laminin 5 into the extracellular matrix and in cell adhesion. J. Cell Biol. 153, 835-850.
19. Gagnoux-Palacios, L., Hervouet, C., Spirito, F., Roques, S., Mezzina, M., Danos, O. and Meneguzzi, G. (2005). Assessment of optimal transduction of primary human skin keratinocytes by viral vectors. J. Gene Med. 7, 1178-1186.
20. Gimond, C., van Der Flier, A., van Delft, S., Brakebusch, C., Kuikman, I., Collard, J. G., Fässler, R. and Sonnenberg, A. (1999). Induction of cell scattering by expression of beta1 integrins in beta1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function. J. Cell Biol. 147, 1325-1340.
21. Grøndahl-Hansen, J., Lund, L. R., Ralfkiaer, E., Ottevanger, V. and Danø, K. (1988). Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. J. Invest. Dermatol. 90, 790-795.
22. Herzog, C., Has, C., Franzke, C. W., Echtermeyer, F. G., Schlötzer-Schrehardt, U., Kröger, S., Gustafsson, E., Fässler, R. and Bruckner-Tuderman, L. (2004). Dystroglycan in skin and cutaneous cells: beta-subunit is shed from the cell surface. J. Invest. Dermatol. 122, 1372-1380.
23. Iozzo, R. V. (2005). Basement membrane proteoglycans: from cellar to ceiling. Nat. Rev. Mol. Cell Biol. 6, 646-656.
24. Kobielak, A. and Fuchs, E. (2006). Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin. Proc. Natl. Acad. Sci. USA 103, 2322-2327.
25. Kolly, C., Suter, M. M. and Müller, E. J. (2005). Proliferation, cell cycle exit, and onset of terminal differentiation in cultured keratinocytes: pre-programmed pathways in control of C-Myc and Notch1 prevail over extracellular calcium signals. J. Invest. Dermatol. 124, 1014-1025.
26. Lien, W. H., Klezovitch, O. and Vasioukhin, V. (2006). Cadherin-catenin proteins in vertebrate development. Curr. Opin. Cell Biol. 18, 499-506.
27. Lien, W. H., Stepniak, E. and Vasioukhin, V. (2008). Dissecting the role of cadherincatenin proteins in mammalian epidermis. Proc. Natl. Acad. Sci. USA 105, 15225-15226.
28. Litjens, S. H., de Pereda, J. M. and Sonnenberg, A. (2006). Current insights into the formation and breakdown of hemidesmosomes. Trends Cell Biol. 16, 376-383.
29. Mangnall, D., Smith, K., Bird, N. C. and Majeed, A. W. (2004). Early increases in plasminogen activator activity following partial hepatectomy in humans. Comp. Hepatol. 3, 11.
30. Mimuro, J., Schleef, R. R. and Loskutoff, D. J. (1987). Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor. Blood 70, 721-728.
31. Müller, E. J., Williamson, L., Kolly, C. and Suter, M. M. (2008). Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation? J. Invest. Dermatol. 128, 501-516.
32. Munz, B., Smola, H., Engelhardt, F., Bleuel, K., Brauchle, M., Lein, I., Evans, L. W., Huylebroeck, D., Balling, R. and Werner, S. (1999). Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J. 18, 5205-5215.
33. Nykjaer, A., Conese, M., Christensen, E. I., Olson, D., Cremona, O., Gliemann, J. and Blasi, F. (1997). Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. EMBO J. 16, 2610-2620.
34. Olwin, B. B. and Rapraeger, A. (1992). Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate. J. Cell Biol. 118, 631-639.
35. Owens, P., Han, G., Li, A. G. and Wang, X. J. (2008). The role of Smads in skin development. J. Invest. Dermatol. 128, 783-790.
36. Perez-Moreno, M. and Fuchs, E. (2006). Catenins: keeping cells from getting their signals crossed. Dev. Cell 11, 601-612.
37. Perez-Moreno, M., Song, W., Pasolli, H. A., Williams, S. E. and Fuchs, E. (2008). Loss of p120 catenin and links to mitotic alterations, inflammation, and skin cancer. Proc. Natl. Acad. Sci. USA 105, 15399-15404.
38. Providence, K. M. and Higgins, P. J. (2004). PAI-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair. J. Cell. Physiol. 200, 297-308.
39. Providence, K. M., Higgins, S. P., Mullen, A., Battista, A., Samarakoon, R., Higgins, C. E., Wilkins-Port, C. E. and Higgins, P. J. (2008). SERPINE1 (PAI-1) is deposited into keratinocyte migration "trails"and required for optimal monolayer wound repair. Arch. Dermatol. Res. 300, 303-310.
40. Rezniczek, G. A., Konieczny, P., Nikolic, B., Reipert, S., Schneller, D., Abrahamsberg, C., Davies, K. E., Winder, S. J. and Wiche, G. (2007). Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan. J. Cell Biol. 176, 965-977.
41. Rheinwald, J. G. and Green, H. (1975). Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6, 331-343.
42. Risbridger, G. P., Schmitt, J. F. and Robertson, D. M. (2001). Activins and inhibins in endocrine and other tumors. Endocr. Rev. 22, 836-858.
43. Rømer, J., Lund, L. R., Eriksen, J., Ralfkiaer, E., Zeheb, R., Gelehrter, T. D., Danø, K. and Kristensen, P. (1991). Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. J. Invest. Dermatol. 97, 803-811.
44. Rømer, J., Pyke, C., Lund, L. R., Ralfkiaer, E. and Danø, K. (2001). Cancer cell expression of urokinase-type plasminogen activator receptor mRNA in squamous cell carcinomas of the skin. J. Invest. Dermatol. 116, 353-358.
45. Sulyok, S., Wankell, M., Alzheimer, C. and Werner, S. (2004). Activin: an important regulator of wound repair, fibrosis, and neuroprotection. Mol. Cell. Endocrinol. 225, 127-132.
46. Toriseva, M. and Kähäri, V. M. (2009). Proteinases in cutaneous wound healing. Cell. Mol. Life Sci. 66, 203-224.
47. Urbano, J. M., Torgler, C. N., Molnar, C., Tepass, U., López-Varea, A., Brown, N. H., de Celis, J. F. and Marti{dotless}́n-Bermudo, M. D. (2009). Drosophila laminins act as key regulators of basement membrane assembly and morphogenesis. Development 136, 4165-4176.
48. Vailly, J., Gagnoux-Palacios, L., Dell'Ambra, E., Roméro, C., Pinola, M., Zambruno, G., De Luca, M., Ortonne, J. P. and Meneguzzi, G. (1998). Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia. Gene Ther. 5, 1322-1332.
49. Vasioukhin, V., Bauer, C., Degenstein, L., Wise, B. and Fuchs, E. (2001). Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell 104, 605-617.
50. Vidal, F., Aberdam, D., Miquel, C., Christiano, A. M., Pulkkinen, L., Uitto, J., Ortonne, J. P. and Meneguzzi, G. (1995). Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat. Genet. 10, 229-234.
51. Vleugels, N., Leys, J., Knockaert, I. and Declerck, P. J. (2000). Effect of stabilizing versus destabilizing interactions on plasminogen activator inhibitor-1. J. Pharm. Belg. 55, 57-58.
52. Watt, F. M. (2002). Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J. 21, 3919-3926.
53. Whitelock, J. M., Murdoch, A. D., Iozzo, R. V. and Underwood, P. A. (1996). The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J. Biol. Chem. 271, 10079-10086.
54. Wysocki, A. B., Kusakabe, A. O., Chang, S. and Tuan, T. L. (1999). Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wound Repair Regen. 7, 154-165.
55. Yi, C. F., Gosiewska, A., Burtis, D. and Geesin, J. (2001). Incorporation of fluorescent enzyme substrates in agarose gel for in situ zymography. Anal. Biochem. 291, 27-33.
56. Yurchenco, P. D. and Patton, B. L. (2009). Developmental and pathogenic mechanisms of basement membrane assembly. Curr. Pharm. Des. 15, 1277-1294.
57. Zybailov, B., Coleman, M. K., Florens, L. and Washburn, M. P. (2005). Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. Anal. Chem. 77, 6218-6224.